WBHF/CMS/ HST/4T-44-2021/NABL/2021/ 153/GROUP-VI

Barium Chloride Powder

Barium Sulphate Powder(175gm)

Basic Fuchsin

Benedict Solution

Bile Esculin Disc

Bile salt

BIVALENT ANTIGEN-DETECTING RAPID DIAGNOSTIC TESTS (RDTs) FOR P. FALCIPARUM AND P. VIVAX MALARIA UNDR NVBDCP TECHNICAL SPECIFICATIONS: - A. Description of the Test Kit: The Bivalent Rapid Diagnostic Test (RDT) for Malaria should comprise of test card (cassette) and reagents including buffer solution in a dropping bottle. The test kit should be able to rapidly diagnose both P. Falciparum and P. Vivax. The test should be based on the principle of capture of parasite antigen from blood using monoclonal antibodies specific for antigen targets. Each test kit should contain all the materials required for performing the test including individually packed sterile lancets for pricking, heparinised capillary tubes (diameter-1mm) with relevant markings and reaction tubes with stand /wells as required. The manufacturer should have specified International Organisation for Standardization (ISO) certification. One should be able to perform the test with the blood taken by finger prick of the patient. Temperature stability data: information on thermal stability data for the lab product should be available. TYPE OF RDT- The RDT should be able to detect P. Falcciparaum Histidine –Rich Protein – 2 (HRP2) and P. Vivax Lactate Dehyydrogenase (pLDH) and not aldolase. RDT Performance Criteria :- The products should conform to the following set of criteria (A-D), based on the results of the evaluation of the WHO Malaria RDT Product Testing. A. For the detection of Plasmodium falciparum (Pf) in all transmission settings the panel detection score (PDS) against Pf samples should be at least 75% at 200 parasites/uL. B. For the detection of Plasmodium Vivax (Pv) in all transmission settings the panel detection score (PDS) against Pv samples should be at least 75% at 200 parasites /uL. C. The false positive rate should be less than 10% . D. The invalid rate should be less than 5%. Each lot of RDT should be tested at a designed lot testing laboratory by using WHO protocol at the time of delivery. Only those lots with PASS report will be accepted for delivery. Content of Kit and Packaging: Each kit should be hermetically sealed in non-permeable pouch and should have moisture absorbent material. 10 such test cards (cassette), or lesser quantity as required by the programme should be packed in a box containing the reagents and the test plates. Adequate literature detailing the test kit components, principle , methodologies and validity criteria as specified under ‘RDT performance criteria’ should be provided in the kit inserts with the test kits. Storage conditions, expiry dates and limitations of test should be provided. The small box should be packed in bigger cardboard carton containing 5 such small boxes. The carton should be sealed with a sealing tape. C. Shelf Life : Shelf life from manufacturing date to expiry date should be at least 2 years and the RDTs should not have lost more than 1/6th of their effective life from the date at the time the material is offered for inspection .Losses due to premature deterioration as a result of biological and other activities during the life of potency of the Rapid Diagnostic Tests will be made good by the firm at its own cost. D. Stability requirements at temperatures of intended storage, transport and use : RDTs should have high thermal stability for use in areas with very high ambient temperatures as per the evaluation by WHO Malaria RDT Product Testing against a single cultured P. falciparum isolate at 200 parasites /uL at based line and after 60 days of incubation at room temperature, 35°C and 45° C. E. Quality Assurance :- The product should comply with ISO 13485. F. Marking /Labelling: i. Each card (cassette) should have space for recording particulars of patients, time and date of the test. ii. The large carton (containing 10 small boxes) and small box (containing 10 tests) should have the following markings: a. Name of the Test b. Lot number c. Manufacturing and expiry date d. Name of the manufacturer with address e. Details of the contents f. Storage conditions. g. Handling procedures h. Disposal instruction for the box and its contents i. GOI,NVBDCP Supply –NOT FOR SALE G. Details regarding approval of license: i. Manufacturing and Marketing License for manufacturing of Rapid Malaria Diagnostic Tests should have been obtained from the concerned Regulatory authority in the country by the manufacturer. ii. The Bidders must submit scientific study report in support of their claim of performance criteria of the offered product, i.e. WHO FIND report mentioning the Panel detection score, false positivity rate, invalid rate, ease of use ,thermal stability data etc. Claim should be supported by reports of actual shelf life studies. iii. Reports of proven performance of the offered product in conditions similar to Indian field conditions (room temperature up to 40° C) with certification of no adverse report for the offered product from the end users during the last five years must be submitted with the bid. iv. The Bidders must submit a sample of their product (for example as two kits to procurement Agent for assessment of user friendliness by the Procurement Agent. v. Recommended conditions for storage (e.g. room temperature) and shelf life should clearly be mentioned on the label of RDT. H. Shipping from manufacturer : Before shipping : The manufacturer should provide to the consignees the details of airway bill numbers, airline carrier, flight number, numbers of containers, expected arrival tiem . These details should be sent by email and flowed up by fax. The shipper (air carrier) should be notified of temperature storage requirements by the manufacturer in writing and by clear markings on cartons and related documents.(Stowage of the shipment close to the skin of some aircraft may result in freezing.) The manufacturer should initiate shipment only when the consignee has confirmed the receipt of shipping notification. Manufacturer should ensure/arrange to have customs agents or other personnel on site to receive materials. Shipments should be moved immediately to moderate temperature storage places (less than 30° C ) .Leaving materials on airport tarmacs, in customs sheds , or in vehicles should be avoided. I. Ground Transportation : Ground transportation should be carried out during any stage of delivery without delay, maintaining temperature requirements while the vehicle is moving and is parked. Avoid leaving RDTs in vehicles parked in the sun.

Bleaching Powder - IS 1065 /1989 [Containing not less than 30% w/w of available chlorine & Stability (max.) = 1 / 15 ]

Boric Acid IP.

Bovine Albumin I.P. (10 ml Vial)

Brain Heart Infusion Agar

Brain Heart Infusion Broth

Calcium Reagent Test Kit

Canada Balsam

CEA ELISA KIT

Cedarwood Oil 25 gms.

Cedarwood Oil 30 ml

Cefaclor Antibiotic Disc

Cefadroxyl Antibiotic Disc

Cefazolin Antibiotic Disc

Cefdinir Antibiotic Disc

Cefepime Antibiotic Disc

Cefixime Antibiotic Disc

Cefoperazone Antibiotic Disc

Cefoperazone/ Salbactam Antibiotic Disc

Cefotaxime Antibiotic Disc

Cefpirome Antibiotic Disc

Cefpodoxime Antibiotic Disc

Cefprozil Antibiotic Disc

Ceftazidime Antibiotic Disc

Ceftizoxime Antibiotic Disc

Ceftriaxone /Salbactum Antibiotic Disc

Ceftriaxone Antibiotic Disc

Cefuroxime Antibiotic Disc

Cefuroxime Sodium Antibiotic Disc

Cephalexin Antibiotic Disc

Cephaloridine Antibiotic Disc

Cephalothin Antibiotic Disc

Chloramphenicol Antibiotic Disc

Chlorhexidine Gluconate 4% w/v for Surgical Scrubbing

Chloroform A.G.

Chlorohexidine Gluconate 3%(w/v) and Strong Cetrimide 6% Solution

Cholesterol - Test Kit

Ciprofloxacin Antibiotic Disc

Citric Acid

Citrosteril Disinfectant Chemical Lotion

Clarithromycin Antibiotic Disc

Clindamycin Antibiotic Disc

Cloxacillin Antibiotic Disc

Collodian

Conc. Hydrochloric Acid

Conc. Sulphuric Acid

Coombs Diluents (Gel System)

Cord Blood Processing Kit (CBP Kit) for the Cord Blood Bank 1. The CBP Kit must consist of three bags integrally connected by tubing, two of which are PVC bags-one larger bag & one smaller bag and a third smallest bag which is the Cryo bag / freezing bag. 2. The larger bag should have a fill volume of 200ml with an attached spike for transferring content from a different collection bag. It must have one leak proof access port for injecting chemicals inside or taking out sample. One additional entry port to this bag is preferred for injecting chemicals only through the nozzle of the syringe without using needle with very narrow calibre connecting tubing for administration of Cryoprotectant(s). 3. Other smaller bag should have a fill volume of 150ml. It must have one leak proof access port for injecting chemicals inside or taking samples from the bag. 4. The third integrally attached bag (Cryo bag / Freezing bag) consists of EVA material or approved material for storing stem cells at ultra low temperature (minus 196˚C) of liquid nitrogen. It must be a 3D bag (3 dimensional) with two compartments of 20ml & 5ml capacity with intercommunication. 5. Length of this Cryo bag/Freezing bag is 85-87mm & width 63-65mm (However the total width is 71-73mm including the height of the two ports (for connecting spike for transplant) of the bag one connected with the 20ml part and other connected with the 5ml part. This Cryo bag/Freezing bag along with at least 90mm integral tube segment should fit inside the metal cassette with dimension 91-92mm (Length) X 84-85mm (Width) X 8-9mm (thickness) for preservation. 6. Temperature range of storage should be minus 196˚C plus 40˚C. 7. Easily manipulative clamp must be present on every connecting tubing from bag to bag and from bag to spike and bag to entry or exit ports. 8. The kit should have an expiry of at least 2 years from the date of manufacture. 9. The kit manufacturing process should follow the national and or international standards like ISO etc. so that the bags are pyrogen free, sterilised, animal pathogenicity test passed, can withstand the shearing force during centrifugation etc. 10. Should provide copy of the supply order to other national or international cord blood banks. 11. Should provide customer satisfaction certificate for the product. 12. Specimen of the kit must be provided to the tender committee for precise verification of the size, shape, measurement and other specifications. 13. Other requirement (if approved and order is placed for purchase):-Each supply lot/batch has to be provided with Certificate of Analysis (quality assurance certificate) otherwise the kit will not be accepted. 14. Should have ICMED 13485 Certification by QCI or IS / ISO 13485 Certification or CE Certificate or US FDA approval Certificate.

Co-trimoxazole Antibiotic Disc

CPK (MB) Test Kit

CPK Test Kit

C-Reactive Protein (Immunoterbedimetric) - Test Kit

Creatinine -Test Kit

Cresol with Soap Solution 50% I.P.

De Ionized Water

Dengue Detection Kit (IgG Antibody) -Elisa

Dengue IgM capture ELISA kit Technical Specification: 1) The ELISA kit should be designed for qualitative detection of dengue IgM antibodies of all 4 dengue serotypes in human serum. 2) The kit should be provided with the following materials and reagents: a. Anti-Human IgM coatedBreak-apart Microwells (12*8=96 wells). Desiccant should be provided for storing the unused Microwells which are to be resealed immediately. b. Horseradish peroxidase conjugated monoclonal antibody tracer with preservatives. c. Chromogenic substrate in buffer. d. Positive Control in the form of positive human serum with preservatives and antibiotics. e. Negative control in the form of confirmed negative human serum with preservatives and antibiotics. f. Calibrators. g. Sample diluents. h. Wash buffer. i. Stop solution. 3) The time required for performing the test for detection of dengue IgM,should range between 2-4 hours. 4) The ELISA kit for detection of dengue IgM should have a sensitivity of >95% and a specificity of >98%. 5) The kit should be such that, one well is to be consumed for evaluation of each sample (barring the wells used for control). 6) Test ELISA kit should distinguish between Dengue and other diseases with similar clinical presentation. 7) The kit should have a shelf-life of at least one year when stored at an ambient temperature of 2ºC - 8ºC. 8) Transportation should be under cold chain 9) Test kit should fit in all the commonly available Brand/Make of ELISA reader & washer machine. 10) The volume of each and every reagents or consumables supplied in a pack (for 96 wells) should be such that, tests can be run at least in twelve occasions by using the 96 wells. 11) User certificates from the reputed institution.

Dengue NS1 Antigen detection kit (Elisa)

Developer (X-Ray film)

Disinfectant Fluids (Black), Phenolic Type, Grade 3 (RW coeff 5-7) IS 1061:1997

Doxycyclin Antibiotic Disc

Drabkin’s Solution

Durham’s Tube

E.D.T.A. Powder

Esbachs Reagent

Estradiol Elisa Kit

Ethanol 95% v/v (Rectified Spirit) - 100 ml

Ethanol 95% v/v(Rectified Spirit)

Ether Solvent

FERRITIN- Elisa

Fixer (X-Ray film)

Formaldehyde Tablet

Formalin Solution 40%

fPSA - Elisa

French Chalk

FSH - Elisa

FT3- Elisa

FT4- Elisa

Furazolidone Antibiotic Disc

Gamma Benzene Hexachloride 1% w/v + Cetrimide 0.1% w/v

Gentamicin Antibiotic Disc

Giemsa Stain 25 mg.

Glacial Acetic Acid

Glucose Test Kit

Glucose-6-Phosphate Dehydrogenase- Test Kit

Glucostix [One Glucometer must be supplied free of cost per 500 strips of Glucostix]

Gluteraldehyde Solution 2% for Instrument Sterilisation

Glycerin I.P.

Glycin Irrigation Fluid

Gram Stain Kit

H2S Strip Kit

Haemodialysis Fluid with Bi-Carb

Hamatoxyllin Eosin Stain Powder

Hand Disinfactant : Each 100 gm Soln. contains : 2- Propanol- 45g, 1-Propanol- 30g, Ethyl-Hexadecyl- Dimethyl - Ammonium Ethyl Sulphate - 0.2 g

Hand Rub Soln.: 0.5% W/V Chlorhexidine Gluconate & 70 % v/v Ethanol

HbA1C Test kit

HbsAg (Elisa) Kit Specification: 1. Microplate ELISA coated with monoclonal antibodies to HBsAG. 2. The assay should be able to detect surface antigen to Hepatitis B virus. 3. Adequate documents detailing the principle, components, bio-safety, methodologies, validity criteria, interpretation of results, performance characteristics, storage conditions limitation of assays, manufacturing & expiry dates should be provided with each kit. 4. The kit to be procured should have approval of the statutory authority in its country of origin. 5. In case of imported kits it should have been registered and licensed in India by DCG(I) . 6. In case of indigenous manufacturers they shall have license issued by the competent authority defined under Drugs and Cosmetics Act, 1940, after appropriate evaluation by the centers approved by DCG(I). 7. The kit should have minimum shelf life of 60% or 12 months (whichever is more) at the port of discharge of consignees. 8. The assay component should include reactive and non-reactive controls. 9. The assay should have sensitivity of more than or equal to 99% and specificity of more than or equal to 98% 10. The assay should have analytical sensitivity of detecting less than or equal to 0.5ng/ml. 11. The manufacturer/authorized agent should ensure maintenance of cold chain during storage & transport the kits at 2°C - 8°C . The cumulative time temperature indicator technology used should be pre-qualified by WHO. 12. The Kit size should be 96 tests /kit. 13. The item should be Up graded from III Generation to IV Generation Test Kit in the light of BTS TRG recommendation dated 12th January 2015.

HBsAg (Rapid) Kit Specification: 1. Should be solid phase/particle coated with monoclonal antibodies to HBsAg. 2. The assay should be able to detect surface antigen to Hepatitis B virus. 3. Adequate documents detailing the principle, components, bio-safety, methodologies, validity criteria, interpretation of results, performance characteristics, storage conditions, limitation of assays, manufacturing & expiry dates should be provided with each kit. 4. The kit to be procured should have approval of the statutory authority in its country of origin. 5. In case of imported kits it should be registered and licensed in India by DCG(I) . 6. In case of indigenous manufacturers they should be licensed by the competent authority defined under Drugs and Cosmetics Act, 1940, after appropriate evaluation by the centers approved by DCG(I). 7. The kit should have minimum shelf –life of 60% or 12 months (whichever is more) at the port of discharge of consignees. 8. The total procedure time shall not be more than 30 minutes. 9. The assay component should include positive and Negative control in each pack of 50 tests. 10. The assay should have sensitivity of more than or equal to 99% and specificity of more than or equal to 98%. 11. The assay should have analytical sensitivity of detecting less than or equal to 0.5ng/ml. 12. The manufacturer/authorized agent should ensure maintenance of cold chain during storage & transport the kits at 2°C - 8°C . The cumulative time temperature indicator technology used should be pre-qualified by WHO. 13. The pack size should not be more than 50 tests wherein each test in individually packed. 14. The item should be Up graded from III Generation to IV Generation Test Kit in the light of BTS TRG recommendation dated 12th January 2015.

HCV (Elisa) Kit Specification: 1. Microplate ELISA Coated with recombinant / synthetic peptide antigens for core, NS3, NS4 and NS5. 2. Adequated documents detailing the principle, components, bio-safety, methodologies, validity criteria, interpretation of results, performance characteristics, storage conditions, limitation of assays ,manufacturing & expiry dates should be provided with each kit. 3. The kit to be procured should have approval of the statutory authority in its country of origin. 4. In case of imported kits it should have been registered and licensed in India by DCG(I). 5. In case of indigenous manufactures they shall have license issued by the competent authority defined under Drugs and Cosmetics Act, 1940, after appropriate evaluation by the centers approved by DCG(I). 6. The kits should have minimum shelf-life of 60% or 12 months (whichever is more) at the port of discharge of consignees. 7. The assay component should include reactive and non-reactive controls. 8. The assay should have a sensitivity more than or equal to 99% and specificity of more than or equal to 98%. 9. The manufacturer / authorized agent should ensure maintenance of cold chain during storage & transport the kits at 2°C - 8°C. The cumulative time temperature indicator technology used should be pre-qualified by WHO. 10. The kit size should be 96 test/.kit. 11. The item should be Up graded from III Generation to IV Generation Test Kit in the light of BTS TRG recommendation dated 12th January 2015.

HCV (Rapid) Kit Specification: 1. Should be solid phase/particle coated with recombinant and / or synthetic peptide antigens for Core,NS3,NS4 and NS5. 2. Adequate documents detailing the principle, components, bio-safety, methodologies, validity criteria, interpretation of results, performance characteristics, storage conditions, limitation of assays, manufacturing & expiry dates should be provide with each kit. 3. The kit to be procured should have approval of the statutory authority in its country of origin 4. In case of imported kits it should have been registered and licensed in India by DCG(I). 5. In case of indigenous manufactures they should be licensed by the competent authority defined under Drugs and Cosmetics Act, 1940, after appropriate evaluation by the centers approved by DCG(I). 6. The kit should have minimum shelf-life of 60% or 12 months (whichever is more) at the port of discharge of consignees. 7. The total procedure time shall not be more than 30 minutes. 8. The assay component should include positive and Negative control in each pack of 50 tests. 9. The assay should have sensitivity of more than or equal to 99% and specificity or more than or equal to 98%. 10. The manufacture / authorized agent should ensure maintenance of cold chain during storage & transport the kits at 2°C - 8°C. The cumulative time temperature indicator technology used should be pre-qualified by WHO. 11. The Pack size should not be more than 50 tests wherein each test is individually packed. 12.The item should be Up graded from III Generation to IV Generation Test Kit in the light of BTS TRG recommendations dated 12th January 2015.

HDL Cholesterol - D (Immunoterbedimetric) Test Kit

Hepatitis A test Kit

Hepatitis E test Kit

HIV (Elisa) Kit Specification: 1. Should be solid phase microplate Coated HIV I & II Recombinant and/or synthetic peptide antigens. 2. The assay should detected HIV 1 and II antibodies. 3. Adequate documents detailing the principal, components, details of antigen for antibody detection of HIV 1and 2, bio-safety, methodologies, validity criteria, interpretation of results, performance characteristics, storage condition, limitation of assays, manufacturing & expiry dates should be provide with each kit. 4.The kit should have approval of the statutory authority in its country of origin. 5.In case of Imported kits it should be registered and licensed in India by DCG(I) 6. In case of indigenous manufacturers should be licensed issued by the competent authority defined under Drugs and Cosmetics Act, 1940 & also be evaluated by the centers approved by DCG(I) 7.The kit should have minimum shelf-life of 60% or 12 months (whichever is more) at the port of discharge of consignees . 8.The assay component should includ reactive and non-reactive controls with each kit. 9.The assay should have sensitivity level of more than or equal to 99.5% and specificity level of more than or equal to 98%. 10.The manufacture / authorized agent should ensure maintenance of cold chain during storage and transport the kits at 2°C - 8°C . The cumulative time temperature indicator technology used should be pre-qualified by WHO. 11. The pack size should be 96 tests/kit. 12.The item should be Up graded from III Generation to IV Generation Test Kit in the light of BTS TRG recommendation dated 12th January 2015.

HIV (Rapid) Testing Kits [By Principal of Enzyme Immuno Assay, Agglutination, or any other Principle] Specification :- 1. Should be a solid phase coated HIV I & HIV II recombinant and / or synthetic peptide antigens. 2. The assay should detect HIV I & II antibodies in plasma,serum or whole blood. 3. Adequte documents detailing the principle , components, details of antigen for antibody detection of HIV I & II, bio-safety, methodologies, validity criteria, interpretation of results, performance characteristics, storage conditions, limitation of assays, manufacturing & expiry dates should be provided with each kit. 4. The kit should have approval of the statutory authority from the country of origin. 5. In case of imported kits it should be registered and licensed by DCG(I). 6. In case of indigenous manufacturers should be licensed by the competent authority defined under Drugs and Cosmetics Act 1940,also be evaluated by the centers approved by DCG(I). 7. The kit should have minimum shelf-life of 60% or 12 months (whichever is more) at the port of discharge of consignees. 8. The time required for performing the test should not be more than 30 minutes. 9. The control dot/band should be able to detect the presence of human immunoglobulins and should not be just a “procedural control” or meant for merely checking the flow of reagents or integrity of the antigen. 10. The assay should have sensitivity of more than or equal to 99.5% and specificity of more than or equal to 98%. 11. The manufacturers should ensure that : a. The test kit should be packed such that there is a provision to conduct single test at a time; b. The assay components should include HIV positive and negative serum control sufficient for conducting 20% of the tests (10% negative and 10% positive controls);and c. The pack size of HIV rapid test kits should not be more that 50 tests per kit. 12. The manufacturer/authorized agent should ensure maintenance of cold chain during storage & transport the kits at 2°C - 8°C. The cumulative time temperature indicator technology used should be pre-qualified by WHO. 13. The item should be Up graded from III Generation to IV Generation Test Kit in the light of BTS TRG recommendation dated 12th January 2015.

HsCRP Test Kit

Hydrogen Peroxide 11% w/v +diluted Silver Nitrate 0.01% w/v

Hydrogen Peroxide Soln. (20Vol) I.P.

Imipenem/Cilastatin Antibiotic Disc

Immersion Oil

Indole strip

Iodine Crystal , A.R.

Isoprophyl Alcohol IP 70% v/v

Kanamycin Antibiotic Disc

KIT FOR EARLY DIAGNOSIS OF PREGNANCY BY IMMUNOLOGICAL METHOD (HCG)

KOH Solution 10% L

Lactate Test Kit

LDL Direct Diagnostic Kit

Leishman Stain Soln.

Levofloxacin Antibiotic Disc

LH kit - Elisa

Lincomycin Antibiotic Disc

Lineazolid Antibiotic Disc

Lipase Test Kit

Liquid Paraffin I.P. (Heavy)

Liquified Phenol I.P. (Carbolic Acid)

Lomefloxacin Antibiotic Disc

Mac Conkey Agar

Magnesium Sulphate I.P.

Malachite Green

MB/BACT Antibiotic Suppliment Kit

Meropenem Antibiotic Disc

Methyl Alcohol

Methyl Violet

METHYLENE BLUE Liquid

METHYLENE BLUE Powder

Micro Protein Test Kit

Minocyclin Antibiotic Disc

Moxifloxacin Antibiotic Disc

Mueller Hintone Agar

Multistrips- 8 Parameter (Alb,Glucose, pH, Ketone, Blood, Bilirubin, Urobilinogen & Nitrite)

Muritic Acid

Nalidixic Antibiotic Disc

Netilmycin Antibiotic Disc

Nitric Acid

Nitrofurantoin Antibiotic Disc

Norfloxacin Antibiotic Disc

O.T.sterilization solution for fumigation/mopping, in powder form, Composition :-Potassium Mono per Sulphate (Triple Salt )- 40% to 50 %, Sodium C 10-13 Alkyl benzene Sulphate - 10% to 20% and Sodium Chloride - 1% to 5%.

Ofloxacin Antibiotic Disc

Paraffin Wax 58 c to 60 c

Paraffin Wax 60 c X 62 c

Penicillin Antibiotic Disc

Peptone

pH paper range 1 to 14

Piperacillin Antibiotic Disc

Pipercillin-Tazobactam Antibiotic Disc

Poly Sodium Citrate

Potassium Iodide

Potassium Permanganate I.P.

PPA Media

Primary Antibody ER

Primary Antibody HER

Primary Antibody PR

Progesterone Elisa Kit

PROLACTIN - Elisa

Providone Iodine cleansing solution 7.5% w/v surgical scrub

PT Reagent

Purified Water I.P.

PYR Reagent

PYR strip

Rapid diagnostic kit for Kala-azar (RK-39)

Rheumatoid Factor (Immunoterbedimetric) Test Kit

Rifampicin Antibiotic Disc

Roxithromycin Antibiotic Disc

RPR (Rapid Plasma Reagin) Kit Specification: 1. The indigenous RPR (Rapid Plasma Reagin) kits should have been manufactured under manufacturing license issued by the State Licensing Authority under the Drugs and Cosmetics Act. The imported kits should have been imported under import License issued by the DCG(I) under Drugs and Cosmetics Act. 2. The assay should allow for qualitative and semi quantitative determination of Reagin antibodies in serum or plasma for sero-diagnosis of syphilis based on flocculation principle using non treponemal antigens. 3. The assay should be suitable to perform with either serum or plasma 4. The assay should have sensitivity of 85% or more in primary syphilis and a specificity of 93% or more. 5. The assay should be calibrated to WHO reference serum and the same should be supported by statements in kit insert and certificate from manufacturer. 6. The test should be able to yield results within 20 minutes. 7. The pack size of RPR test kit should be less than or equal to 50 tests per kit. 8. The assay components should include positive and negative serum control sufficient for conducting 20% of the tests (10% negative and 10% positive controls). 9. The kit should have all essential accessories required for the test such as cards, droppers, applicator etc. in adequate quantities for the number of tests to be performed. 10. The kit should have minimum shelf-life of 60% or 12 months (whichever is more) at the port of discharge of consignees. 11. The cumulative time temperature indicator technology used should be pre-qualified by WHO. 12. Literature, detailing the components, methodologies, validity criteria, performance characteristics, storage conditions, manufacturing and expiry dates should be provided with each kit. 13. The item should be Up graded from III Generation to IV Generation Test Kit in the light of BTS TRG recommendation dated 12th January 2015.

Sabouraud Dextrose Agar (SDA) with CC

Serum Billirubin Test kit

SGOT Test Kit

SGPT Test Kit

Simmons Citrate Agar

Sodium Hypochloride – 500 ml Bot.

Solution for instrumental sterilization in powder form, Composition : Sodium Perborate Monohydrate 50% w/w (0.26% per acetic acid)

Sparfloxacin Antibiotic Disc

Streptomycin Antibiotic Disc

Surface Disinfactant Soln (Each 100 gm Contains: 1,6 Di-Hydroxy 2,5 Di-Oxyhexane (Chemically Bound Formaldehyde ) - 11.2 gms , Glutaraldehide 5 gm , Benzalkonium Chloride 5 gm, Alkyl Urea Derivatives 3 gms

T4 - Elisa

TCBS Agar

Teicoplanin Antibiotic Disc

Tetracyclin Antibiotic Disc

Ticarcillin/Clavulanic Acid Antibiotic Disc

Tobramycin Antibiotic Disc

Toludine Blue

Total Protein Test Kit

STANDARD ANALYTICAL LABORATORY ND PVT LTD

Delhi Test House

Delhi Test House

ITL LABS PVT. LTD